Skip to content
10-Q

Quarterly Report

PSS WORLD MEDICAL INC

0001193125-13-041164

← back to feed
Filed
Feb 6, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Feb 1, 2013 50.33M sh
Shares Diluted Q3 2012 · Dec 28, 2012 52.25K sh
Shares Diluted Q3 2012 · Dec 28, 2012 50.86K sh
Shares Diluted restated Q3 2012 · Dec 30, 2011 52.44K sh
Shares Diluted restated Q3 2012 · Dec 30, 2011 54.59K sh
Stock Repurchased Q3 2012 · Dec 28, 2012 $7.8M
Stock Repurchased Q3 2012 · Dec 30, 2011 $115.76M
Capex Q3 2012 · Dec 28, 2012 $16.46M
Capex restated Q3 2012 · Dec 30, 2011 $15.62M
Operating Cash Flow Q3 2012 · Dec 28, 2012 $86.49M
Operating Cash Flow Q3 2012 · Dec 30, 2011 $65.97M
Short Term Debt Q3 2012 · Dec 28, 2012 $212.39M
Short Term Debt Q3 2012 · Mar 30, 2012 $0
Cash And Equivalents Q3 2012 · Dec 28, 2012 $216.13M
Cash And Equivalents Q3 2012 · Mar 30, 2012 $163.15M
Cash And Equivalents Q3 2012 · Dec 30, 2011 $32.44M
Cash And Equivalents Q3 2012 · Apr 1, 2011 $29.35M
Stockholders Equity Q3 2012 · Dec 28, 2012 $448.27M
Stockholders Equity Q3 2012 · Mar 30, 2012 $387.13M
Current Liabilities Q3 2012 · Dec 28, 2012 $496.02M
Current Liabilities Q3 2012 · Mar 30, 2012 $201.81M
Total Liabilities Q3 2012 · Dec 28, 2012 $855.45M
Total Liabilities Q3 2012 · Mar 30, 2012 $765.16M
Current Assets Q3 2012 · Dec 28, 2012 $909.7M
Current Assets Q3 2012 · Mar 30, 2012 $821.46M
Total Assets Q3 2012 · Dec 28, 2012 $1.31B
Total Assets Q3 2012 · Mar 30, 2012 $1.16B
Eps Diluted Q3 2012 · Dec 28, 2012 $0.74
Eps Diluted Q3 2012 · Dec 28, 2012 $1.27
Eps Diluted Q3 2012 · Dec 30, 2011 $0.38
Eps Diluted Q3 2012 · Dec 30, 2011 $1.00
Eps Basic Q3 2012 · Dec 28, 2012 $0.78
Eps Basic Q3 2012 · Dec 28, 2012 $1.31
Eps Basic Q3 2012 · Dec 30, 2011 $0.39
Eps Basic Q3 2012 · Dec 30, 2011 $1.03
Sga Expense Q3 2012 · Dec 28, 2012 $83.86M
Sga Expense Q3 2012 · Dec 28, 2012 $241.81M
Sga Expense restated Q3 2012 · Dec 30, 2011 $70.44M
Sga Expense restated Q3 2012 · Dec 30, 2011 $210.05M
Net Income Q3 2012 · Dec 28, 2012 $38.72M
Net Income Q3 2012 · Dec 28, 2012 $64.73M
Net Income Q3 2012 · Dec 30, 2011 $20.13M
Net Income Q3 2012 · Dec 30, 2011 $54.35M
Operating Income Q3 2012 · Dec 28, 2012 $24.01M
Operating Income Q3 2012 · Dec 28, 2012 $72.23M
Operating Income restated Q3 2012 · Dec 30, 2011 $27.94M
Operating Income restated Q3 2012 · Dec 30, 2011 $77.95M
Gross Profit Q3 2012 · Dec 28, 2012 $145.41M
Gross Profit Q3 2012 · Dec 28, 2012 $423.88M
Gross Profit restated Q3 2012 · Dec 30, 2011 $131.08M
Gross Profit restated Q3 2012 · Dec 30, 2011 $383.68M
Cost Of Revenue Q3 2012 · Dec 28, 2012 $288.5M
Cost Of Revenue Q3 2012 · Dec 28, 2012 $840.22M
Cost Of Revenue restated Q3 2012 · Dec 30, 2011 $263.12M
Cost Of Revenue restated Q3 2012 · Dec 30, 2011 $782.72M
Revenue Q3 2012 · Dec 28, 2012 $433.91M
Revenue Q3 2012 · Dec 28, 2012 $1.26B
Revenue restated Q3 2012 · Dec 30, 2011 $394.2M
Revenue restated Q3 2012 · Dec 30, 2011 $1.17B